Immune Th17 lymphocytes play a critical role in the multiple beneficial properties of resveratrol.

Fiche publication

Date publication

décembre 2019

Journal

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association

Auteurs

Membres identifiés du Cancéropôle Est :
Pr DELMAS Dominique , Pr GHIRINGHELLI François , Dr AIRES Virginie , Dr LIMAGNE Emeric

Tous les auteurs :
Delmas D, Limagne E, Ghiringhelli F, Aires V

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31883989

Résumé

Modulation of the inflammatory response is one of the major issues of the 21st century due to its importance in the occurrence of various pathologies (cancer, autoimmune diseases, degenerative diseases) and their progression over time. Whether acute or chronic, the inflammatory response is directly related to the immune response through different subtypes of T lymphocytes. In addition, among the compounds capable of modulating the cells of the immune system, resveratrol, a polyphenol with pleiotropic biological properties, seems to be a good candidate. Indeed, resveratrol is able to alter the immune response by modulating the process of lymphocyte differentiation and subsequently diminishing the inflammatory-associated response. More specifically, thanks to its ability to act as a sirtuin-1 agonist, it can deacetylate the transcription factor STAT3 and alter nuclear factors essential to the process of lymphocyte differentiation. We present and discuss these different aspects in relation to various pathologies and how the alteration of the ratios between the different lymphocyte subtypes by resveratrol is an important element to take into account when studying its anti-inflammatory and immunomodulatory properties.